Inhibition of EGFR-TKI-induced autophagy was reported to contribute to TKI resistance in NSCLC with EGFR mutations (Gorzalczany et al., 2011; Wei et al., 2013). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.